Say hello to a special edition of MassDevice +3, a bite-sized view of the top three med-tech stories coming out of the JP Morgan health care conference in San Francisco. Stay tuned the rest of this week for more breaking medical device news!
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Pleasanton, Calif.-based Thoratec is getting into the ring with Abiomed (NSDQ:ABMD), preparing its version of a percutaneous heart pump to compete with the Impella device that Abiomed already has on the market, CEO Gary Burbach said at the JP Morgan health care conference this morning.
The Pipeline stroke-treatment device Covidien plc (NYSE:COV) acquired with its $2.6 billion acquisition of ev3 Inc. is gaining share in markets across the globe, CEO Jose Almeida told analysts this morning at the JP Morgan health care conference.
After 7 months on the job, Medtronic CEO Omar Ishrak laid out his vision for transforming the world’s largest pure-play medical device maker today at his first appearance at the J.P. Morgan health care conference in San Francisco.